To date, the enhanced CD163 expression on alveolar/circulating M2 in ILD such as idiopathic pulmonary fibrosis (IPF) and systemic sclerosis has been demonstrated, respectively [44, 45]. This evidence concerns the gene CD163 and systemic sclerosis.